ERBB2 and gastric cancer: A trimeric HER2-targeting DNA aptamer, 2-2(t), previously reported in human gastric cancer cells (Mahlknecht et al., 2013), and one of our selected 10 aptamers with the lowest affinity to HER2 (M9), were utilized for comparison with HMAP7.